The US has delivered the first 1,000 doses of Lenacapavir to Eswatini and Zambia, starting its African rollout despite major aid cuts.

Washington plans to fund two million doses by 2028 through partnerships with Gilead and the Global Fund. The twice-yearly drug is expected to sharply reduce new HIV infections.

For Advert, Event Coverage/Press Conference Invite, Story/Article Publication & Other Media Services
Contact Us On WhatsApp
Send Email To: citizennewsng@gmail.com
Visit Citizen NewsNG To Read More Latest and Interesting News Across Nigeria and the World